Healthcare company Hestia Insight Inc (OTCMKTS:HSTA) did not see much action in its stock yesterday and it traded largely within a range. That being said, the company remains interesting and may well prove to be a good proposition for investors. Hestia Insight is involved in both the healthcare as well as biotech sectors and it manages to do so through two separate fully owned subsidiary units. One of those is Hestia Investments Inc and the other one is HSTA Health Inc.
On Wednesday, HSTA stock ended flat at $2.80 with 100 shares, compared to its average volume of 34 shares. The stock moved within a range of $2.8000 – 2.8000 after opening trade at $2.80.
About Hestia Investments
Hestia Investments is involved in providing consulting services, marketing and management support, sales of medical supplies, and advice on capital markets for small to medium-sized companies in the healthcare as well as biotech sectors.
As you can see, the company performs a vital function in overseeing the potential growth of small to medium-sized companies in two critical sectors and that may make it worth looking into at this point despite the fact that the stock was trading in a range yesterday.
Hestia Insight Relaunches Effort to Assist Asian Companies Gain Access to U.S. Public Markets
Hestia Insight was actually in the news on Wednesday that it was going to expand its presence in Asia. In order to accomplish that, it announced that it had engaged the services of the Taiwanese firm PK International. PK International is going to be engaged in acting as the company’s sales and marketing agent in its quest to expand into Asia. The Chief Executive Officer and Chairman of Hestia Edward C Lee noted that the COVID 19 pandemic had been a disaster for many companies and hence, Hestia was making efforts for companies in Asia that may be interested in getting access to the public markets in the United States.
However, that was not all. It was also announced by the company that it was exploring ways to put in place a mergers and acquisitions strategy. In order to accomplish that, the company decided to put together a highly experienced team, which is going to oversee the strategy. Hestia is going to be particularly focused on such companies which are involved in the nutrition, wellness, and healthcare sectors.
“After the disastrous worldwide impact of COVID-19, we are relaunching our effort to reach Asian companies that are interested in gaining access to the U.S. public markets,” said Edward C. Lee, the Company’s Chief Executive Officer, and Chairman.
HSTA stock is trading below the 20-Day and 50-Day Moving averages of $3.12 and $3.31 respectively. Moreover, the stock is trading below the 200-Day moving average of $4.21.